Computational Repurposing of FDA Approved Drugs Against Cyclin Dependent Kinase (CDK2)
Drug repurposing is an approach for identifying new therapeutic with existing FDA approved drugs. Cyclin-dependent kinase 2 (CDK2) is an important regulator of cell cycle progression. The present study aimed to identify FDA-approved drugs with potential binding activity against CDK2 using a Computational drug-repurposing approach. The crystal structure of Human CDK2 (PDB ID: 3PY0) was used for…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
